Cargando…
Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324661/ https://www.ncbi.nlm.nih.gov/pubmed/30647865 http://dx.doi.org/10.18632/oncotarget.26460 |
| _version_ | 1783386010453803008 |
|---|---|
| author | Eyre, Toby A. |
| author_facet | Eyre, Toby A. |
| author_sort | Eyre, Toby A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6324661 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63246612019-01-15 Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? Eyre, Toby A. Oncotarget Editorial Impact Journals LLC 2018-12-18 /pmc/articles/PMC6324661/ /pubmed/30647865 http://dx.doi.org/10.18632/oncotarget.26460 Text en Copyright: © 2018 Eyre. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Eyre, Toby A. Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title | Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title_full | Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title_fullStr | Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title_full_unstemmed | Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title_short | Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? |
| title_sort | predictive biomarkers for disease sensitivity in lymphoma – the holy grail for hdac inhibitors? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324661/ https://www.ncbi.nlm.nih.gov/pubmed/30647865 http://dx.doi.org/10.18632/oncotarget.26460 |
| work_keys_str_mv | AT eyretobya predictivebiomarkersfordiseasesensitivityinlymphomatheholygrailforhdacinhibitors |